Oishii Plus Co. Ltd. announced that it has raised in a round of funding on May 18, 2023. the transaction included participation from new investor, Rohto Pharmaceutical Co.,Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,055 JPY | -3.87% | -0.33% | +6.75% |
04-04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
04-04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.75% | 4.7B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Oishii Plus Co. Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.